Bernard Ravina's Net Worth
$6.19 Million
Who is Bernard Ravina?
Bernard Ravina has an estimated net worth of $6.19 Million. This is based on reported shares across multiple companies, which include Praxis Precision Medicines, Inc., and Voyager Therapeutics, Inc..
SEC CIK
Bernard Ravina's CIK is 0001711276
Past Insider Trading and Trends
2021 was Bernard Ravina's most active year for acquiring shares with 3 total transactions. Bernard Ravina's most active month to acquire stocks was the month of December. 2017 was Bernard Ravina's most active year for disposing of shares, totalling 6 transactions. Bernard Ravina's most active month to dispose stocks was the month of December. 2021 saw Bernard Ravina paying a total of $102,150.00 for 135,312 shares, this is the most they've acquired in one year. In 2017 Bernard Ravina cashed out on 43,920 shares for a total of $637,663.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $54.3
Chief Medical OfficerBernard Ravina owns 99,476 units of Common Stock which is worth $5,401,546.80. In the year 2020 Bernard Ravina acquired a total of 91,512 shares in Praxis Precision Medicines, Inc. at a cost of $102,150.00, Bernard also disposed a total of 3,057 shares of Praxis Precision Medicines, Inc. equalling to $39,282.45.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| -2.98% | -3.06K |
$12.85 | -$39,282.45 | 99.48K |
Feb 12
| |||
Form 4
| +27.32% | 22K |
—
|
—
| 102.53K |
Jan 7
| |||
Form 4
| +43.76% | 24.51K |
—
|
—
| 80.53K |
Feb 12
| |||
Form 4
| +408.31% | 45K |
$2.27 | $102,150.00 | 56.02K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Chief Medical OfficerBernard Ravina used to own units in Common Stock but no longer holds any shares there. In the year 2017 Bernard Ravina filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.45K |
$18.38 | -$45,049.38 |
0
|
Scheduled
|
Apr 10
| ||
Form 4
| -50.00% | -2.45K |
$25.16 | -$61,667.16 | 2.45K |
Scheduled
|
Mar 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -33.33% | -2.45K |
$18.24 | -$44,706.24 | 4.9K |
Scheduled
|
Feb 12
| ||
Form 4
| -33.05% | -3.63K |
$16.40 | -$59,532.00 | 7.35K |
Scheduled
|
Jan 10
| ||
Form 4
| -33.33% | -5.49K |
$13.63 | -$74,828.70 | 10.98K |
Scheduled
|
Dec 11
| ||
Form 4
| -25.00% | -5.49K |
$13.26 | -$72,797.40 | 16.47K |
Scheduled
|
Nov 10
| ||
Form 4
| -33.33% | -10.98K |
$20.33 | -$223,223.40 | 21.96K |
Scheduled
|
Oct 10
| ||
Form 4
| -16.67% | -16.47K |
$12.15 | -$211,914.00 | 82.36K |
Scheduled
|
Jul 20 - Sep 11
| ||
Form 4
| -24.24% | -5.49K |
$10.00 | -$54,900.00 | 17.16K |
Scheduled
|
Sep 5
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |